Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen.
Catia MarzoliniMatthias CavassiniDominique L BraunAnna HachfeldEnos BernasconiAlexandra CalmyPatrick SchmidManuel BattegayLuigia Elzinull nullPublished in: British journal of clinical pharmacology (2023)
The lipid-lowering effect of statins tended to be attenuated by SLCO1B1 polymorphism and progressively declined as total cholesterol under the boosted protease inhibitor treatment decreased.